Cue Health Inc. (HLTH)
Cue Health Statistics
Share Statistics
Cue Health has 159.09M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 159.09M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 97.14M |
| Failed to Deliver (FTD) Shares | 1.68M |
| FTD / Avg. Volume | 7.68% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.07 and the forward PE ratio is null. Cue Health's PEG ratio is 0.
| PE Ratio | -0.07 |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | null |
| PB Ratio | 0.1 |
| P/FCF Ratio | -0.16 |
| PEG Ratio | 0 |
Enterprise Valuation
Cue Health has an Enterprise Value (EV) of -8.91M.
| EV / Sales | -0.13 |
| EV / EBITDA | 0.04 |
| EV / EBIT | 0.06 |
| EV / FCF | 0.06 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.54 |
| Quick Ratio | 2.22 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | -0.2 |
| Debt / FCF | -0.3 |
| Interest Coverage | -256.01 |
Financial Efficiency
Return on Equity is -149.24% and Return on Invested Capital is -100.8%.
| Return on Equity | -149.24% |
| Return on Assets | -109.91% |
| Return on Invested Capital | -100.8% |
| Revenue Per Employee | $97.71K |
| Profits Per Employee | $-514.41K |
| Employee Count | 726 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 9.05 |
Taxes
| Income Tax | 4.79M |
| Effective Tax Rate | -1.3% |
Stock Price Statistics
The stock price has increased by -71.63% in the last 52 weeks. The beta is 1.09, so Cue Health's price volatility has been higher than the market average.
| Beta | 1.09 |
| 52-Week Price Change | -71.63% |
| 50-Day Moving Average | 0.08 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 25.44 |
| Average Volume (20 Days) | 21.93M |
Income Statement
In the last 12 months, Cue Health had revenue of 70.94M and earned -373.46M in profits. Earnings per share was -2.44.
| Revenue | 70.94M |
| Gross Profit | -56.16M |
| Operating Income | -296.71M |
| Net Income | -373.46M |
| EBITDA | -240.44M |
| EBIT | -367.51M |
| Earnings Per Share (EPS) | -2.44 |
Balance Sheet
The company has 81.69M in cash and 47.94M in debt, giving a net cash position of 33.75M.
| Cash & Cash Equivalents | 81.69M |
| Total Debt | 47.94M |
| Net Cash | 33.75M |
| Retained Earnings | -591.54M |
| Total Assets | 283.66M |
| Working Capital | 30.6M |
Cash Flow
In the last 12 months, operating cash flow was -137.81M and capital expenditures -19.8M, giving a free cash flow of -157.61M.
| Operating Cash Flow | -137.81M |
| Capital Expenditures | -19.8M |
| Free Cash Flow | -157.61M |
| FCF Per Share | -1.03 |
Margins
Gross margin is -79.16%, with operating and profit margins of -418.28% and -526.48%.
| Gross Margin | -79.16% |
| Operating Margin | -418.28% |
| Pretax Margin | -519.72% |
| Profit Margin | -526.48% |
| EBITDA Margin | -338.95% |
| EBIT Margin | -418.28% |
| FCF Margin | -222.19% |
Dividends & Yields
HLTH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1503.32% |
| FCF Yield | -634.44% |
Analyst Forecast
Currently there are no analyst rating for HLTH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -5.62 |
| Piotroski F-Score | 3 |